Sipurzynski-Budrass S, Posch U, Stubenvoll E, Gombotz H, Lanzer G
Department für Transfusionsmedizin und Immunhämatologie, Chirurgische Universitätsklinik, LKH Graz, Osterreich.
Beitr Infusionsther Transfusionsmed. 1996;33:201-5.
Low basal hemoglobin and functional iron deficiency are the limiting factors in autologous blood donation program. Treatment with recombinant human erythropoietin can increase the volume of autologous blood and makes donation of > or = 3 units possible-even in patients with low basal hemoglobin. Best results are obtained if stimulation begins already one week before first donation.
低基础血红蛋白水平和功能性缺铁是自体输血计划的限制因素。使用重组人促红细胞生成素进行治疗可增加自体血容量,使捐献≥3单位血液成为可能——即使是基础血红蛋白水平较低的患者。如果在首次献血前一周就开始刺激,效果最佳。